Literature DB >> 9230250

Body composition and health-related quality of life in patients with obstructive airways disease.

R Shoup1, G Dalsky, S Warner, M Davies, M Connors, M Khan, F Khan, R ZuWallack.   

Abstract

This study evaluated the effects of body weight and lean mass abnormalities on health-related quality of life (HRQL) in obstructive airways disease. Body weight, lean mass (using dual-energy X-ray absorptiometry), and HRQL (using the St George's Respiratory Questionnaire (SGRQ)) were measured in 50 patients. Low lean mass was defined as a lean mass index (lean mass/height2) below the fifth percentile of a control population. Dyspnoea was measured by the baseline dyspnoea index. The mean (SD) age was 69+/-9 yrs; the forced expiratory volume in one second (FEV1) was 39+/-19% of predicted. Patients had 2.4+/-4.1 kg less lean mass than predicted. Increased dyspnoea was the most influential predictor of poor HRQL. Compared to normal-weight patients, those who were underweight had significantly greater impairment in activity, impact, and total SGRQ scores, while those who were overweight had greater impairment in impact and total SGRQ scores. Low lean mass was associated with greater impairment in symptoms, activity and impact subscores and the total SGRQ score. When dyspnoea was added to the model as a covariate, neither weight nor lean mass remained significantly related to HRQL. Thus, although body weight and lean mass abnormalities influence health-related quality of life, their effects appear to be mediated through increased levels of dyspnoea.

Entities:  

Mesh:

Year:  1997        PMID: 9230250     DOI: 10.1183/09031936.97.10071576

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

Review 1.  A practical guide to bioelectrical impedance analysis using the example of chronic obstructive pulmonary disease.

Authors:  Anja Walter-Kroker; Axel Kroker; Muriel Mattiucci-Guehlke; Thomas Glaab
Journal:  Nutr J       Date:  2011-04-21       Impact factor: 3.271

Review 2.  Health status measurement in chronic obstructive pulmonary disease.

Authors:  P W Jones
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

Review 3.  [Chronic bronchitis, COPD].

Authors:  H R Wirtz
Journal:  Internist (Berl)       Date:  2005-02       Impact factor: 0.743

4.  Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD.

Authors:  Charlotte E Bolton; Roelinka Broekhuizen; Alina A Ionescu; Lisette S Nixon; Emiel F M Wouters; Dennis J Shale; Annemie M W J Schols
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

5.  Altered tissue distribution in adults with cystic fibrosis.

Authors:  C E Bolton; A A Ionescu; W D Evans; R J Pettit; D J Shale
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

6.  Raw BIA variables are predictors of muscle strength in patients with chronic obstructive pulmonary disease.

Authors:  F de Blasio; M G Santaniello; F de Blasio; G Mazzarella; A Bianco; L Lionetti; F M E Franssen; L Scalfi
Journal:  Eur J Clin Nutr       Date:  2017-09-13       Impact factor: 4.016

7.  Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients.

Authors:  I Sermet-Gaudelus; J C Souberbielle; I Azhar; J C Ruiz; P Magnine; V Colomb; C Le Bihan; D Folio; G Lenoir
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

8.  Underweight and overweight men have greater exercise-induced dyspnoea than normal weight men.

Authors:  Mirza M F Subhan; Syed A Ali; Syed S I Bokhari; Mohammed N Khan; Hakimuddin R Ahmad
Journal:  Ups J Med Sci       Date:  2012-08-30       Impact factor: 2.384

Review 9.  Skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  M J Mador; E Bozkanat
Journal:  Respir Res       Date:  2001-05-02

10.  Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study.

Authors:  Merry-Lynn N McDonald; Alejandro A Diaz; James C Ross; Raul San Jose Estepar; Linfu Zhou; Elizabeth A Regan; Eric Eckbo; Nina Muralidhar; Carolyn E Come; Michael H Cho; Craig P Hersh; Christoph Lange; Emiel Wouters; Richard H Casaburi; Harvey O Coxson; William Macnee; Stephen I Rennard; David A Lomas; Alvar Agusti; Bartolome R Celli; Jennifer L Black-Shinn; Greg L Kinney; Sharon M Lutz; John E Hokanson; Edwin K Silverman; George R Washko
Journal:  Ann Am Thorac Soc       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.